The Regulatory Reporting Hub of Deutsche Börse Group has launched a partnership with Risk Focusand its software subsidiary, RegTek.Solutions, headquartered in New York. Risk Focus will provide key system components for the Regulatory Reporting Hubs’ OTC Trade Reporting solution, including RegTek.Solutions’ Validate.Trade product.
The functionality of the components provided by Risk Focus and RegTek.Solutions includes interpretation of instrument details of OTC derivatives submitted in FpML or XML format as well as a rules engine for applying the regulatory validations, eligibility checks and deferrals.
“In the dynamic environment with frequent updates of regulatory details, the approach to using a rules engine has already proven to be very useful. OTC trade reporting is one of the backbones of MiFID II, which is going to be effective as of January 2018. Deutsche Börse’s MiFID II OTC trade reporting service will provide clients with an efficient and simple-to-use way of meeting their OTC transparency requirements in accordance with the new regulation,” said Georg Gross, Head of Regulatory Services at Deutsche Börse.
“Given the extreme time pressure that firms are under to comply with MiFID II, we are proud to provide a version of Validate.Trade to all users of the Deutsche Börse’s Trade Reporting Services that allows them to start testing their OTC Trade Report Submissions straightaway. Our partnership with Deutsche Börse will enable us to combine existing and custom components to bring this important MiFID II Trade Reporting Service to market,” said Lloyd Altman, Partner, Risk Focus.
Deutsche Börse Group has concentrated its solutions for regulatory compliance onto one platform – the Regulatory Reporting Hub. This Hub enables sell-side and buy-side clients as well as corporates and trading venues to meet their regulatory obligations efficiently and reliably – publication requirements as well as reporting to all relevant National Competent Authorities, covering multiple regulations.